日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Human DNA levels in feces reflect gut inflammation and associate with presence of gut species in IBD patients across the age spectrum

粪便中的人类DNA水平反映了肠道炎症,并与IBD患者(涵盖所有年龄段)肠道菌群的存在相关。

Mazzoni, Chiara; Ochana, Bracha-Lea; Orlanski-Meyer, Esther; Ya'acov, Ami Ben; Focht, Gili; Harpenas, Esty; Shmorak, Shimrit; Ledder, Oren; Lev-Tzion, Raffi; Shemer, Ruth; Shteyer, Eyal; Dor, Yuval; Yassour, Moran

Disease activity classification based on routinely collected blood tests in a prospective paediatric inflammatory bowel disease inception cohort

基于前瞻性儿科炎症性肠病初始队列中常规采集的血液检查结果的疾病活动度分类

Lujan, Rona; Ledder, Oren; Yogev, Dotan; Lev-Tzion, Raffi; Orlanski-Meyer, Esther; Yuval Bar-Asher, Shira; Shamasnah, Ibrahim; Shteyer, Eyal; Gotesdyner, Leora; Shawar, Mohammad; Feldman, Elena; Aschkenasy, Gabriella; Lev, Anna; Turner, Dan

Vedolizumab for extraintestinal manifestations in pediatric inflammatory bowel disease: Results from the VedoKids study

维多珠单抗治疗儿童炎症性肠病肠外表现:VedoKids 研究结果

D'Arcangelo, Giulia; Turner, Dan; Ledder, Oren; Orlanski-Meyer, Esther; Broide, Efrat; Granot, Maya; Matar, Manar; Hussey, Seamus; Yerushalmy-Feler, Anat; Norden, Christoph; Miele, Erasmo; Aloi, Marina

Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study

基线药物清除率可预测接受维多珠单抗治疗的炎症性肠病患儿的预后:来自 VedoKids 前瞻性多中心研究的结果

Stein, Ronen; Turner, Dan; Hussey, Séamus; Kawasmi, Aysha; Ledder, Oren; Levine, Jeremiah; Markowitz, James; Matar, Manar; Orlanski-Meyer, Esther; Russell, Richard K; Shaoul, Ron; Yerushalmy-Feler, Anat; Mould, Diane R; Conrad, Maire A

Lactobacillus lysates protect oral epithelial cells from pathogen-associated damage, increase secretion of pro-inflammatory cytokines and enhance barrier integrity

乳酸杆菌裂解物可保护口腔上皮细胞免受病原体相关损伤,增加促炎细胞因子的分泌,并增强屏障完整性。

Mercer, Steven D; Doherty, Christopher; Singh, Gurdeep; Willmott, Thomas; Cheesapcharoen, Tanaporn; Teanpaisan, Rawee; O'Neill, Catherine; Ledder, Ruth G; McBain, Andrew J

Long-term outcome of pediatric acute severe colitis: A prospective 5-year follow-up of the PRASCO trial

儿童急性重症结肠炎的长期预后:PRASCO试验的前瞻性5年随访

Lachman, Dan; Orlanski-Meyer, Esther; Lev-Tzion, Raffi; Ledder, Oren; Assa, Amit; Shavit-Brunschwig, Zivia; Yerushalmi, Baruch; Aloi, Marina; Griffiths, Anne M; Albenberg, Lindsey; Bar-Or, Itzhak; Kolho, Kaija-Leena; Shouval, Dror S; Cohen, Shlomi; Turner, Dan; Atia, Ohad

Ethnic Disparities in the Management of Inflammatory Bowel Disease in Israel and Impact on Outcomes

以色列炎症性肠病治疗中的种族差异及其对治疗结果的影响

Boaz, Elad; Ledder, Oren; Bar-Gil Shitrit, Ariella; Dagan, Amir; Freund, Michael R; Koslowsky, Benjamin; Lujan, Rona; Greenfeld, Shira; Kariv, Revital; Loewenberg Weisband, Yiska; Lederman, Natan; Matz, Eran; Dotan, Iris; Turner, Dan; Yellinek, Shlomo

Serum Metabolites Relate to Mucosal and Transmural Inflammation in Paediatric Crohn Disease

血清代谢物与儿童克罗恩病的黏膜和全层炎症相关

Suarez, Ricardo G; Guruprasad, Namitha; Tata, Ganesh; Zhang, Zhengxiao; Focht, Gili; McClement, Daniel; Navas-López, Víctor Manuel; Koletzko, Sibylle; Griffiths, Anne M; Ledder, Oren; de Ridder, Lissy; Wishart, David; Nichols, Ben; Gerasimidis, Konstantinos; Turner, Dan; Wine, Eytan

Drugs in focus: Botulinum toxin in the therapy of gastrointestinal disorders in children

重点药物:肉毒杆菌毒素在儿童胃肠道疾病治疗中的应用

Homan, Matjaž; Thomson, Mike; Bontems, Patrick; Saccomani, Marco Deganello; Dias, Jorge Amil; Faraci, Simona; Furlano, Raoul; Hojsak, Iva; Ledder, Oren; Slae, Mordechai; Narula, Priya; Nita, Andreia Florina; Norsa, Lorenzo; Oliva, Salvatore; Papadopoulou, Alexandra; Romano, Claudio; Rybak, Anna; Spyropoulou, Vasiliki; Tambucci, Renato; Tzivinikos, Christos; van Wijk, Michiel; Borrelli, Osvaldo

Escherichia coli Nissle 1917 inhibits biofilm formation and mitigates virulence in Pseudomonas aeruginosa

大肠杆菌 Nissle 1917 可抑制生物膜形成并减轻铜绿假单胞菌的毒力

Ahmad M Aljohani, Cecile El-Chami, Muna Alhubail, Ruth G Ledder, Catherine A O'Neill, Andrew J McBain